Share-based Payment Arrangement, Expense of Mural Oncology plc from 30 Sep 2022 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Mural Oncology plc quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Sep 2022 to 30 Sep 2025.
  • Mural Oncology plc Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $109,000, a 89% decline year-over-year.
  • Mural Oncology plc Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $163,000, a 99% decline year-over-year.
  • Mural Oncology plc annual Share-based Payment Arrangement, Expense for 2024 was $5,081,000, a 79% decline from 2023.
  • Mural Oncology plc annual Share-based Payment Arrangement, Expense for 2023 was $24,109,000, a 102% increase from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Mural Oncology plc Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $163,000 $109,000 -$921,000 -89% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $1,084,000 $1,121,000 -$2,311,000 -194% 01 Apr 2025 30 Jun 2025 10-Q 04 Aug 2025 2025 Q2
Q1 2025 $3,395,000 $513,000 -$1,686,000 -77% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $5,081,000 $662,000 -$14,570,000 -96% 01 Oct 2024 31 Dec 2024 10-K 11 Mar 2025 2024 FY
Q3 2024 $19,651,000 $1,030,000 -$1,953,000 -65% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $21,604,000 $1,190,000 -$1,951,000 -62% 01 Apr 2024 30 Jun 2024 10-Q 04 Aug 2025 2025 Q2
Q1 2024 $23,555,000 $2,199,000 -$554,000 -20% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q4 2023 $24,109,000 $15,232,000 01 Oct 2023 31 Dec 2023 10-K 11 Mar 2025 2024 FY
Q3 2023 $2,983,000 -$496,000 -14% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 $3,141,000 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $2,753,000 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q3 2022 $3,479,000 01 Jul 2022 30 Sep 2022 10-Q 14 Dec 2023 2023 Q3

Mural Oncology plc Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $5,081,000 -$19,028,000 -79% 01 Jan 2024 31 Dec 2024 10-K 11 Mar 2025 2024 FY
2023 $24,109,000 +$12,178,000 +102% 01 Jan 2023 31 Dec 2023 10-K 11 Mar 2025 2024 FY
2022 $11,931,000 01 Jan 2022 31 Dec 2022 10-K 26 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.